Wyndly

Candidature YC de Wyndly

Winter 2021Active

Wyndly a été sélectionné par Y Combinator dans le cadre du batch Winter 2021 en tant qu'entreprise Healthcare. Ci-dessous : ce que fait l'entreprise, qui l'a fondée, et sa candidature à YC, reconstruite question par question dans le vrai formulaire YC.

Batch YC
Winter 2021
Secteur d'activité
HealthcareConsumer Health and Wellness
Taille de l'équipe
10
Statut
Active
Lancé
2021

Fondateurs

  • Aakash Shah
    Aakash ShahFounder & CEO
  • Manan Shah
    Manan ShahFounder

Ce que fait Wyndly

Wyndly ( fixes allergies by training patients' bodies to ignore their allergy triggers. Frustrated allergy suffers come to us when they no longer want to deal with pills and sprays. We diagnose the patient’s unique allergy profile and create a personalized treatment plan to give the patient lifelong allergy relief. Specifically, Wyndly is increasing access to sublingual immunotherapy (SLIT) for allergy care. For our patients, we're combining the convenience of telehealth and direct-to-consumer care with an exceptional patient experience that never loses the context of care. Wyndly represents an opportunity to change allergy care forever. With 60 million Americans suffering from allergies today, and with this number doubling over the coming years, there's simply an incredible need for the convenient care Wyndly provides. You can read more about us in [Techcrunch]( The Wyndly Model At Wyndly, we believe that better connections lead to better care, and we’re committed to making both happen at every step of the patient journey. Our allergy practice allows our patients to work with expert providers to develop personalized treatment plans for long-term allergy relief using clinically proven therapies. From a patient’s initial consultation to their final treatment delivery, we want the Wyndly experience to be a breath of fresh air for allergy sufferers - truly effective allergy relief, simply and efficiently delivered. Once we've conquered allergies, we're transforming the care model for every chronic condition. While transactional care for purchasing pills has flourished in telehealth, no one has gone after chronic care. Patients with chronic conditions are shuffled between providers, insurance, and more -- and they never feel heard. These patients deserve better, and we're going to give it to them. Wyndly is starting with allergies, but we'll expand into asthma, sleep apnea, and other conditions in the near future. Our values **Compassion**: We approach all our patients and partners with an open mind and a genuine desire to be of service. **Focus**: We do a few things very well, and are always clear about our boundaries and direction of travel. **Courage**: We embrace ambiguity and discomfort because we know that’s how we grow. **Progress**: We make something better every single day. *It boils down to empathy and forward momentum in everything we do.* The team Wyndly is proudly backed by Y Combinator and a leading group of angel investors and VCs. The founders are Dr. Manan Shah (Chief Medical Officer), an ear-nose-and-throat surgeon who’s a leading practitioner of telehealth in his specialty, and his cousin Aakash Shah (CEO), who led growth engineering at SparkGift (acquired by Stockpile in 2016) and Parse.ly (acquired by Automattic in 2021).

Candidature YC de Wyndly, reconstruite

Candidature Y Combinator

Wyndly, promotion Winter 2021. Les vraies questions de candidature, répondues à partir de données publiques.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Wyndly

Describe what your company does in 50 characters or less.

Life's better without allergies

What is your company going to make? Please describe your product and what it does or will do.

We built a telehealth platform that diagnoses patients' unique allergies and delivers personalized sublingual immunotherapy treatment plans. Patients get allergy relief without pills or sprays, combining direct-to-consumer care with expert providers remotely. We focus on making long-term allergy relief accessible and convenient.

Where do you live now, and where would the company be based after YC?

We live in New York, NY, and the company is based here with remote team members.

Explain your decision regarding location.

New York puts us in a large healthcare and tech hub with access to providers and a broad patient market while accommodating remote work for flexibility.

21 réponses supplémentaires dans la candidature complète

se trouvent dans la version complète. Créez un compte gratuit pour l'ouvrir dans YC Insights, à côté de tous les autres batches YC.

Questions fréquemment posées

Est-ce la vraie candidature YC de Wyndly ?

Non. Y Combinator garde les candidatures soumises privées. Ceci est une reconstruction : les vraies questions du formulaire YC, répondues à partir des données publiques de Wyndly (notes de lancement, parcours des fondateurs, description du produit). Cela montre comment une entreprise comme Wyndly se présenterait à YC, pas le texte qu'ils ont soumis.

À quel batch YC Wyndly appartenait-il ?

Wyndly faisait partie du batch Winter 2021 de Y Combinator.

Qui a fondé Wyndly ?

Wyndly a été fondé par Aakash Shah, Manan Shah.

Que fait Wyndly ?

Life's better without allergies

Comment lire la candidature complète reconstruite ?

Créez un compte Round Funded gratuit. La version complète de la candidature de Wyndly en 26 réponses, et de chaque autre promotion YC, se trouve dans YC Insights.

Plus de startups YC comme Wyndly